126 related articles for article (PubMed ID: 1592460)
1. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
Kuchel O; Shigetomi S
Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic abnormalities in borderline essential hypertensive patients.
Shigetomi S; Buu NT; Kuchel O
Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
[TBL] [Abstract][Full Text] [Related]
3. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Shigetomi S; Kuchel O
Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
Kuchel OG; Shigetomi S
Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
[TBL] [Abstract][Full Text] [Related]
5. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
6. Attenuated renal production of dopamine in patients with low renin essential hypertension.
Aoki K; Kikuchi K; Yamaji I; Nishimura M; Honma C; Kobayakawa H; Yamamoto M; Kudoh C; Shimazaki M; Sakamoto T
Clin Exp Hypertens A; 1989; 11 Suppl 1():403-9. PubMed ID: 2663252
[TBL] [Abstract][Full Text] [Related]
7. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
Kuchel O
Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
[TBL] [Abstract][Full Text] [Related]
8. Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertension.
Kuchel O; Shigetomi S
Hypertens Res; 1995 Jun; 18 Suppl 1():S183-5. PubMed ID: 8529056
[TBL] [Abstract][Full Text] [Related]
9. Heart failure, aging, and renal synthesis of dopamine.
Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
[TBL] [Abstract][Full Text] [Related]
10. Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney.
Suzuki H; Nakane H; Kawamura M; Yoshizawa M; Takeshita E; Saruta T
Am J Physiol; 1984 Sep; 247(3 Pt 1):E285-90. PubMed ID: 6433718
[TBL] [Abstract][Full Text] [Related]
11. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
12. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
[TBL] [Abstract][Full Text] [Related]
13. [Dopamine and hypertension].
Sigetomi S; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1993 Oct; 69(9):953-62. PubMed ID: 8262273
[TBL] [Abstract][Full Text] [Related]
14. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
Gill JR; Grossman E; Goldstein DS
Hypertension; 1991 Nov; 18(5):614-21. PubMed ID: 1937664
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic activity and water-sodium handling in the kidneys of essential hypertensive subjects: is renal dopaminergic activity suppressed at the prehypertensive stage?
Iimura O; Shimamoto K; Ura N
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S56-8. PubMed ID: 1708026
[TBL] [Abstract][Full Text] [Related]
16. Altered dopaminergic responses in hypertension.
Clark BA; Rosa RM; Epstein FH; Young JB; Landsberg L
Hypertension; 1992 Jun; 19(6 Pt 1):589-94. PubMed ID: 1592453
[TBL] [Abstract][Full Text] [Related]
17. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
Barendregt JN; Florijn KW; Muizert Y; Chang PC
Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary dopamine excretion in young patients with essential hypertension.
Saito I; Itsuji S; Takeshita E; Kawabe H; Nishino M; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
Clin Exp Hypertens; 1994 Jan; 16(1):29-39. PubMed ID: 8136773
[TBL] [Abstract][Full Text] [Related]
19. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
[TBL] [Abstract][Full Text] [Related]
20. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
